Elevated alcohol consumption in null mutant mice lacking 5-HT1B serotonin receptors. 1996

J C Crabbe, and T J Phillips, and D J Feller, and R Hen, and C D Wenger, and C N Lessov, and G L Schafer
Department of Veterans, Affairs Medical Center, Portland, Oregon, USA.

Substantial evidence links alcohol drinking and serotonin (5-HT) functioning in animals. Lowered central 5-HT neurotransmission has been found in a subgroup of alcoholics, possibly those with more aggressive, assaultive tendencies. Several rodent studies have also suggested that intact 5-HT systems are important determinants of sensitivity and/or tolerance to ethanol-induced ataxia and hypothermia. Null mutant mice lacking the 5-HT1B receptor gene (5-HT1B-/-) have been developed that display enhanced aggression and altered 5-HT release in slice preparations from some, but not all, brain areas. We characterized these mice for sensitivity to several effects of ethanol. Mutant mice drank twice as much ethanol as wild-type mice, and voluntarily ingested solutions containing up to 20% ethanol in water. Their intake of food and water, and of sucrose, saccharin and quinine solutions, was normal. Mutants were less sensitive than wild-types on a test of ethanol-induced ataxia and, with repeated drug administration, tended to develop tolerance more slowly. In tests of ethanol withdrawal and metabolism, mutants and wild-type mice showed equivalent responses. Our results suggest that the 5-HT1B receptor participates in the regulation of ethanol drinking, and demonstrate that serotonergic manipulations lead to reduced responsiveness to certain ataxic effects of ethanol without affecting dependence.

UI MeSH Term Description Entries
D011985 Receptors, Serotonin Cell-surface proteins that bind SEROTONIN and trigger intracellular changes which influence the behavior of cells. Several types of serotonin receptors have been recognized which differ in their pharmacology, molecular biology, and mode of action. 5-HT Receptor,5-HT Receptors,5-Hydroxytryptamine Receptor,5-Hydroxytryptamine Receptors,Receptors, Tryptamine,Serotonin Receptor,Serotonin Receptors,Tryptamine Receptor,Tryptamine Receptors,Receptors, 5-HT,Receptors, 5-Hydroxytryptamine,5 HT Receptor,5 HT Receptors,5 Hydroxytryptamine Receptor,5 Hydroxytryptamine Receptors,Receptor, 5-HT,Receptor, 5-Hydroxytryptamine,Receptor, Serotonin,Receptor, Tryptamine,Receptors, 5 HT,Receptors, 5 Hydroxytryptamine
D004435 Eating The consumption of edible substances. Dietary Intake,Feed Intake,Food Intake,Macronutrient Intake,Micronutrient Intake,Nutrient Intake,Nutritional Intake,Ingestion,Dietary Intakes,Feed Intakes,Intake, Dietary,Intake, Feed,Intake, Food,Intake, Macronutrient,Intake, Micronutrient,Intake, Nutrient,Intake, Nutritional,Macronutrient Intakes,Micronutrient Intakes,Nutrient Intakes,Nutritional Intakes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000428 Alcohol Drinking Behaviors associated with the ingesting of ALCOHOLIC BEVERAGES, including social drinking. Alcohol Consumption,Alcohol Intake,Drinking, Alcohol,Alcohol Drinking Habits,Alcohol Drinking Habit,Alcohol Intakes,Consumption, Alcohol,Drinking Habit, Alcohol,Habit, Alcohol Drinking,Habits, Alcohol Drinking,Intake, Alcohol
D000431 Ethanol A clear, colorless liquid rapidly absorbed from the gastrointestinal tract and distributed throughout the body. It has bactericidal activity and is used often as a topical disinfectant. It is widely used as a solvent and preservative in pharmaceutical preparations as well as serving as the primary ingredient in ALCOHOLIC BEVERAGES. Alcohol, Ethyl,Absolute Alcohol,Grain Alcohol,Alcohol, Absolute,Alcohol, Grain,Ethyl Alcohol
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001259 Ataxia Impairment of the ability to perform smoothly coordinated voluntary movements. This condition may affect the limbs, trunk, eyes, pharynx, larynx, and other structures. Ataxia may result from impaired sensory or motor function. Sensory ataxia may result from posterior column injury or PERIPHERAL NERVE DISEASES. Motor ataxia may be associated with CEREBELLAR DISEASES; CEREBRAL CORTEX diseases; THALAMIC DISEASES; BASAL GANGLIA DISEASES; injury to the RED NUCLEUS; and other conditions. Coordination Impairment,Dyssynergia,Incoordination,Ataxia, Appendicular,Ataxia, Limb,Ataxia, Motor,Ataxia, Sensory,Ataxia, Truncal,Ataxy,Dyscoordination,Lack of Coordination,Tremor, Rubral,Appendicular Ataxia,Appendicular Ataxias,Ataxias,Ataxias, Appendicular,Ataxias, Limb,Ataxias, Motor,Ataxias, Sensory,Ataxias, Truncal,Coordination Impairments,Coordination Lack,Impairment, Coordination,Impairments, Coordination,Incoordinations,Limb Ataxia,Limb Ataxias,Motor Ataxia,Motor Ataxias,Rubral Tremor,Rubral Tremors,Sensory Ataxia,Sensory Ataxias,Tremors, Rubral,Truncal Ataxia,Truncal Ataxias
D013375 Substance Withdrawal Syndrome Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug. Drug Withdrawal Symptoms,Withdrawal Symptoms,Drug Withdrawal Symptom,Substance Withdrawal Syndromes,Symptom, Drug Withdrawal,Symptom, Withdrawal,Symptoms, Drug Withdrawal,Symptoms, Withdrawal,Syndrome, Substance Withdrawal,Syndromes, Substance Withdrawal,Withdrawal Symptom,Withdrawal Symptom, Drug,Withdrawal Symptoms, Drug,Withdrawal Syndrome, Substance,Withdrawal Syndromes, Substance
D044302 Receptor, Serotonin, 5-HT1B A serotonin receptor subtype found at high levels in the BASAL GANGLIA and the frontal cortex. It plays a role as a terminal autoreceptor that regulates the rate of SEROTONIN release from nerve endings. This serotonin receptor subtype is closely related to and has similar drug binding properties as the 5-HT1D RECEPTOR. It is particularly sensitive to the agonist SUMATRIPTAN and may be involved in mediating the drug's antimigraine effect. Serotonin 1B Receptor,5-HT(1B) Receptor,5-HT(1Dbeta) Receptor,5-HT1B Receptor,5-HT1Dbeta Receptor,5-Hydroxytryptamine 1B Receptor,5-Hydroxytryptamine 1B Receptors,Receptor, 5-Hydroxytryptamine 1B,Receptor, Serotonin Type 1Dbeta,Serotonin 1D Beta Receptor,Serotonin 1Dbeta Receptor,Serotonin 1Dbeta Receptors,1B Receptor, 5-Hydroxytryptamine,1B Receptors, 5-Hydroxytryptamine,5 HT1B Receptor,5 HT1Dbeta Receptor,5 Hydroxytryptamine 1B Receptor,5 Hydroxytryptamine 1B Receptors,Receptor, 5 Hydroxytryptamine 1B,Receptor, 5-HT1B,Receptor, 5-HT1Dbeta,Receptor, Serotonin 1B,Receptor, Serotonin 1Dbeta,Receptors, 5-Hydroxytryptamine 1B,Receptors, Serotonin 1Dbeta
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

J C Crabbe, and T J Phillips, and D J Feller, and R Hen, and C D Wenger, and C N Lessov, and G L Schafer
July 1997, Pharmacology, biochemistry, and behavior,
J C Crabbe, and T J Phillips, and D J Feller, and R Hen, and C D Wenger, and C N Lessov, and G L Schafer
August 1999, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
J C Crabbe, and T J Phillips, and D J Feller, and R Hen, and C D Wenger, and C N Lessov, and G L Schafer
July 2000, The European journal of neuroscience,
J C Crabbe, and T J Phillips, and D J Feller, and R Hen, and C D Wenger, and C N Lessov, and G L Schafer
September 1994, Science (New York, N.Y.),
J C Crabbe, and T J Phillips, and D J Feller, and R Hen, and C D Wenger, and C N Lessov, and G L Schafer
March 1999, Neuroscience letters,
J C Crabbe, and T J Phillips, and D J Feller, and R Hen, and C D Wenger, and C N Lessov, and G L Schafer
January 2011, Pharmacological reports : PR,
J C Crabbe, and T J Phillips, and D J Feller, and R Hen, and C D Wenger, and C N Lessov, and G L Schafer
April 1995, Nature,
J C Crabbe, and T J Phillips, and D J Feller, and R Hen, and C D Wenger, and C N Lessov, and G L Schafer
January 2002, European journal of pharmacology,
J C Crabbe, and T J Phillips, and D J Feller, and R Hen, and C D Wenger, and C N Lessov, and G L Schafer
November 1997, Journal of neurochemistry,
J C Crabbe, and T J Phillips, and D J Feller, and R Hen, and C D Wenger, and C N Lessov, and G L Schafer
November 1996, Alcoholism, clinical and experimental research,
Copied contents to your clipboard!